Research Publications
  1. New HBVsubgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India. Ghosh S, Banerjee P, Deny P, Mondal RK, Nandi M, Roychoudhury A, Das K, Banerjee S, Santra A, Zoulim F, Chowdhury A, Datta S.J Viral Hepat. 2013 Mar;20(3):209-18.
  2. Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population. Roy N, Mukhopadhyay I, Das K, Pandit P, Majumder PP, Santra A, Datta S, Banerjee S*, Chowdhury A*. Gene. 2012 Nov 1;509(1):178-88. * Joint Corresponding authors.
  3. Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative infection. Ghosh S, Mondal RK, Banerjee P, Nandi M, Sarkar S, Das K, Santra A, Banerjee S, Chowdhury A, Datta S.ClinMicrobiol Infect. 2012 Oct;18(10)
  4. "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Das K, Sarkar R, Ahmed SM, Mridha AR, Mukherjee PS, Das K, Dhali GK, Santra A, Chowdhury A.Hepatology. 2012 Feb;55(2):584-93.
  5. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Ghatak S, Biswas A, Dhali GK, Chowdhury A, Boyer JL, SantraA.ToxicolApplPharmacol. 2011 Feb 15;251(1):59-69.
  6. Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India. Ghosh S, Banerjee P, RoyChoudhury A, Sarkar S, Ghosh A, Santra A, Banerjee S, Das K, Dwibedi B, Kar SK, Rao VG, Bhat JT, Singh N, Chowdhury A, Datta S.J ClinMicrobiol. 2010 Nov;48(11):4063-71.
  7. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A.Liver Int. 2010 Aug;30(7):1033-42..
  8. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, Dhibar T, Bhattacharya B, Bhattacharya D, Manna B, Dhali GK, Santra A, Chowdhury A.Hepatology. 2010 May;51(5):1593-602.
  9. Hepatic fibrosis: can we treat it clinically? Das K, Chowdhury A.Trop Gastroenterol. 2008 Apr-Jun;29(2):76-83. Review.
  10. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK.ToxicolApplPharmacol. 2007 Apr 15;220(2):146-55. Epub 2007 Jan 9.
  11. Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. Farheen S, Sengupta S, Santra A, Pal S, Dhali GK, Chakravorty M, Majumder PP, Chowdhury A.World J Gastroenterol. 2006 Apr 14;12(14):2269-75.
  12. Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice. Chowdhury A, Santra A, Bhattacharjee K, Ghatak S, Saha DR, Dhali GK.J Hepatol. 2006 Jul;45(1):117-26. Epub 2006 Feb 17.
  13. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, Datta S, Banerji S, Manna B, Chowdhury SR, Bhattacharya SK, Mazumder DG.J Gastroenterol Hepatol. 2005 Nov;20(11):1712-20.
Home Departments OPD Schedule Academics Reports Query Contact Us Research Facilities Infrastructures Notice Board Advertisement